Schedule 13D ownership disclosure
PHASERX, INC.
Security class unavailable · CUSIP: 71723F103
Event date: 2018-04-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,238,979
- Percent of class
- 4.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-038219
- Form type
- SC 13D
- Filer
- CRISPR Therapeutics AG
- CIK
- CIK 1674416
- Filed
- Jun 28, 2019
- Reporting period
- Apr 20, 2018
- Description
- Schedule 13D beneficial ownership